Atara Biotherapeutics ATRA
NASDAQ ATRA
$8.46 -0.04 (-0.47%)
At close: Oct 1, 2026 · 4:00 PM EDT

Atara Biotherapeutics (ATRA) Net Margin (2021 - 2026)

Updated

Atara Biotherapeutics (ATRA) posted Net Margin of -767.30% for Q2 2026, down 780.88 percentage points from 13.58% a year earlier but up 35.99 percentage points from the prior quarter.

Analysis

Atara Biotherapeutics (ATRA) Net Margin (2021 - 2026) Analysis & Trends

For the trailing twelve months through Jun 30, 2026, Net Margin at Atara Biotherapeutics was -269.42%, down 272.49 percentage points year-over-year; for FY2025, it was 27.07%, up 93.30 percentage points from FY2024.

  • Annual Net Margin shows a four-year change of +1699.34 percentage points (FY2021 to FY2025).
  • In prior years, Atara Biotherapeutics' Net Margin was -66.23% in FY2024 (+3154.64 pp), -3220.88% in FY2023 (-2861.91 pp), -358.97% in FY2022 (+1313.31 pp) and -1672.28% in FY2021.
  • Quarterly Net Margin has run from a low of -30069.35% in Q4 2022 to a high of 38.73% in Q1 2025 over five years.
  • On a year-over-year basis, Net Margin has declined in each of the last four quarters, with an average year-over-year change of +370.01 percentage points over the last eight quarters.
  • The strongest year-over-year quarter for Net Margin in the past five years was Q4 2023, with a gain of 28647.67 percentage points; the weakest was Q4 2022, with a drop of 28832.62 percentage points.
  • According to Business Quant data, Net Margin for the three prior quarters was -803.29% (Q1 2026), -213.54% (Q4 2025) and -124.62% (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Margin (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 21.86%
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 21.27%
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn -8.04%
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn 22.61%
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn 18.81%
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 23.62%
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn -134.51%
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn -1.65%
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 32.99%
10 Atara Biotherapeutics 127.78 Mn 117.88 Mn 439,000.00 -767.30%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -767.30%
Mar 31, 2026 -803.29%
Dec 31, 2025 -213.54%
Sep 30, 2025 -124.62%
Jun 30, 2025 13.58%
Mar 31, 2025 38.73%
Dec 31, 2024 -38.75%
Sep 30, 2024 -54.51%
Jun 30, 2024 -66.51%
Mar 31, 2024 -116.07%
Dec 31, 2023 -1,421.68%
Sep 30, 2023 -3,264.59%
Jun 30, 2023 -7,430.30%
Mar 31, 2023 -6,098.78%
Dec 31, 2022 -30,069.35%
Sep 30, 2022 -1,885.87%
Jun 30, 2022 35.80%
Mar 31, 2022 -1,204.61%
Dec 31, 2021 -1,236.74%
Sep 30, 2021 -1,576.61%
API Access

Atara Biotherapeutics Net Margin API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=net-margin&ticker=ATRA&period=max&api_key=YOUR_API_KEY